跳至主要内容
临床试验/NCT00915759
NCT00915759已完成不适用

Sutureless Cryopreserved Amniotic Membrane Graft (ProKera) and Wound Healing After Photorefractive Keratectomy

Walter Reed National Military Medical Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Number of Days to Complete Re-epithelialization

研究概览

简要总结

The purpose of this study is to evaluate the effect of ProKera on corneal wound healing after photorefractive keratectomy (PRK) in terms of re-epithelialization, pain, adverse effects, visual recovery, refractive accuracy, and corneal clarity.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Active duty US Army Soldiers eligible for care at WRAMC.
  • Male or female, of any race, and at least 21 years old at the time of the preoperative examination, and have signed and informed consent. The lower age limit of 21 years is intended to ensure documentation of refractive stability.
  • Subject must expect to be located in the greater Washington, District of Columbia area for a 12 month period post-operatively.
  • Consent of the subject's command (active duty) to participate in the study.
  • Access to transportation to meet follow-up requirements.

排除标准

  • Any reason to be excluded for PRK.
  • Female subjects who are pregnant, breast-feeding or intend to become pregnant during the study. Female subjects will be give a urine pregnancy test prior to participating in the study to rule out pregnancy. [Pregnancy and breastfeeding are contraindications to refractive surgery in general, including PRK, whether participating in this study or not].
  • Patients with known sensitivity or inappropriate responsiveness to any of the medications used in the post-operative course.
  • Any physical or mental impairment that would preclude participation in any of the examinations.
  • Anterior basement membrane dystrophy.
  • History of recurrent epithelial erosion.
  • Significant dry eye (symptomatic with Schirmer test < 5 mm at 5 minutes).
  • Other corneal epithelial disorder or healing abnormality.
  • Patients with unusually tight eyelids close to the eyeball making it difficult and/ or painful to insert anything (e.g., ProKera) between the eyelid and globe.

结局指标

主要结局

Number of Days to Complete Re-epithelialization

时间窗: participants will be followed daily until complete re-epithelialization, an expected average of 3-5 days post-operatively

measured as number of days to complete re-epithelialization, as assessed by daily examination using slit lamp biomicroscopy

次要结局

  • Post-operative Pain Score Ranging From 0 (None) to 10 (Worst Possible Pain)(Day 1)
  • Number of Eyes With Complications/Adverse Events(up to one year post-operatively)
  • Number of Eyes Achieving Uncorrected Distance Visual Acuity of 20/20 or Better at 12 Months Post-operatively(one year post-operatively)
  • Number of Eyes With Manifest Spherical Equivalent Within +/- 0.50 Diopters of Emmetropia at 12 Months Post-operatively(one year post-operatively)
  • Number of Eyes With Clinically Significant Corneal Haze(one year postoperatively)
  • Tear Total Protein Levels(1 month post-operatively)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Sutureless Cryopreserved Amniotic Membrane Graft... | 临床试验